MY157518A - Dibenzothiazepine derivatives and use thereof - Google Patents

Dibenzothiazepine derivatives and use thereof

Info

Publication number
MY157518A
MY157518A MYPI2010006035A MYPI20106035A MY157518A MY 157518 A MY157518 A MY 157518A MY PI2010006035 A MYPI2010006035 A MY PI2010006035A MY PI20106035 A MYPI20106035 A MY PI20106035A MY 157518 A MY157518 A MY 157518A
Authority
MY
Malaysia
Prior art keywords
disorder
compounds
dibenzothiazepine derivatives
dibenzothiazepine
derivatives
Prior art date
Application number
MYPI2010006035A
Other languages
English (en)
Inventor
Brown Dean
Michael Wood
James R Damewood
Edwards Phil
Hulsizer James
Muir James Campbell
Pierson Jr M Edward
Shenvi Ashokkumar Bhikkappa
Wesolowski Steven
Widzowski Dan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41431860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY157518(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MY157518A publication Critical patent/MY157518A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
MYPI2010006035A 2008-06-20 2009-06-18 Dibenzothiazepine derivatives and use thereof MY157518A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7441708P 2008-06-20 2008-06-20

Publications (1)

Publication Number Publication Date
MY157518A true MY157518A (en) 2016-06-15

Family

ID=41431860

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010006035A MY157518A (en) 2008-06-20 2009-06-18 Dibenzothiazepine derivatives and use thereof

Country Status (37)

Country Link
US (3) US20110160184A1 (https=)
EP (1) EP2307389B1 (https=)
JP (2) JP5468068B2 (https=)
KR (1) KR20110019781A (https=)
CN (1) CN102131791B (https=)
AR (1) AR072200A1 (https=)
AU (1) AU2009260905B2 (https=)
BR (1) BRPI0914231A2 (https=)
CA (1) CA2728675A1 (https=)
CL (1) CL2010001471A1 (https=)
CR (1) CR11860A (https=)
CU (1) CU23884B1 (https=)
CY (1) CY1113845T1 (https=)
DK (1) DK2307389T3 (https=)
DO (1) DOP2010000393A (https=)
EA (1) EA201001889A1 (https=)
EC (1) ECSP10010698A (https=)
ES (1) ES2402084T3 (https=)
HN (1) HN2010002683A (https=)
HR (1) HRP20130234T1 (https=)
IL (2) IL210081A (https=)
ME (1) ME01516B (https=)
MX (1) MX2010014203A (https=)
MY (1) MY157518A (https=)
NI (1) NI201000224A (https=)
NZ (1) NZ590616A (https=)
PE (1) PE20110029A1 (https=)
PL (1) PL2307389T3 (https=)
PT (1) PT2307389E (https=)
RS (1) RS52703B (https=)
SI (1) SI2307389T1 (https=)
SV (1) SV2010003769A (https=)
TW (1) TWI488854B (https=)
UA (1) UA105903C2 (https=)
UY (1) UY31919A (https=)
WO (1) WO2009154563A1 (https=)
ZA (1) ZA201100488B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102131791B (zh) * 2008-06-20 2014-12-24 阿斯利康(瑞典)有限公司 二苯并硫杂氮杂*衍生物及其用途
CN105981027A (zh) * 2013-08-12 2016-09-28 哥莱菲特软件公司 安全认证并切换至加密域
CN103524455A (zh) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
CA2931289C (en) 2013-11-21 2023-10-17 Graphite Software Corporation Managed domains for remote content and configuration control on mobile information devices
CN104447615A (zh) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 喹硫平中间体的制备方法
EP4428132A1 (en) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use
JP2026509430A (ja) * 2023-03-08 2026-03-19 ヨハン ヴォルフガング ゲーテ－ウニベルジテート フランクフルト アム マイン Ｓｌａｃｋ活性化化合物及びその医学的用途

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL293201A (https=)
NL294355A (https=)
DE1620703B2 (de) * 1960-08-16 1976-11-25 Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern 11-basisch substituierte dibenzo eckige klammer auf b,f eckige klammer zu-eckige klammer auf 1,4 eckige klammer zu-thiazepine
CH422793A (de) 1961-07-20 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine
CH476753A (de) 1962-06-08 1969-08-15 Wander Ag Dr A Verfahren zur Herstellung von 11-basisch substituierter Dibenzo(b,f)(1,4)thiazepine
DE1470416A1 (de) 1962-05-25 1969-05-14 Wander Ag Dr A Verfahren zur Herstellung ll-basisch substituierter 5 H-Dibenzo[b,e],[1,4] diazepine
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
NL293210A (https=) 1963-05-09
US3884920A (en) 1967-07-14 1975-05-20 Sandoz Ag 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US3683034A (en) 1963-09-27 1972-08-08 Upjohn Co Process for the preparation of substituted hydroquinones
US3908010A (en) 1967-03-22 1975-09-23 Wander Ag Dr A Basically substituted heterocycles as anti-emetics
US3412193A (en) 1965-12-13 1968-11-19 American Cyanamid Co 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
AT278805B (de) 1966-01-17 1970-02-10 American Cyanamid Co Verfahren zur herstellung von oxazepinen und thiazepinen
NL6715650A (https=) 1966-12-16 1968-06-17
US3852446A (en) 1967-03-13 1974-12-03 Sandoz Ag Organic compounds in treatment of psychotic disturbances
US3758479A (en) 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
US3539573A (en) 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
CH569731A5 (https=) * 1972-04-04 1975-11-28 Wander Ag Dr A
GB8607684D0 (en) 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
JPH0565257A (ja) 1991-07-05 1993-03-19 Hokuriku Seiyaku Co Ltd 多環式化合物及びその用途
US5750566A (en) 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
ATE192157T1 (de) 1994-08-24 2000-05-15 Astra Ab Therapeutisch verwendbare spiro-azabicyclische verbindungen
US5602121A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
WO2000010572A1 (en) 1998-08-18 2000-03-02 Sepracor Inc. Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
SE9900100D0 (sv) 1999-01-15 1999-01-15 Astra Ab New compounds
WO2001008680A1 (de) 1999-07-28 2001-02-08 Oswald Wiss Präparate mit sauerstoffsparender wirkung bei körperlicher leistung
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0002729D0 (sv) 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
US6630462B2 (en) 2000-11-17 2003-10-07 Adolor Corporation Delta agonist analgesics
IL139975A0 (en) 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
PT1395567E (pt) 2001-05-18 2009-03-26 Astrazeneca Ab Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
BR0210075A (pt) 2001-06-01 2004-08-17 Astrazeneca Ab Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa
HRP20040102A2 (en) 2001-07-09 2004-10-31 Combinatorx Combinations for the treatment of inflammatory disorders
ES2379544T3 (es) 2001-09-27 2012-04-27 Ramot At Tel Aviv University Ltd. Conjugado de perfenazina y GABA y usos del mismo
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
ES2348282T3 (es) 2002-04-18 2010-12-02 Astrazeneca Ab Compuestos de tienilo.
US7417049B2 (en) 2002-04-18 2008-08-26 Astrazeneca Ab Furyl compounds
NZ561993A (en) 2002-04-18 2008-09-26 Astrazeneca Ab Spiroazabicyclic heterocyclic amines as potent ligands for nicotinic acetylcholine receptors
SE0202430D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202465D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202598D0 (sv) 2002-09-02 2002-09-02 Astrazeneca Ab Alpha-7 Nicotinic receptor agonists and statins in combination
EP1538906A2 (en) 2002-09-18 2005-06-15 Fmc Corporation Insecticidal tricyclic derivatives
JP2006510697A (ja) * 2002-12-20 2006-03-30 ビーエーエスエフ　アクチェンゲゼルシャフト 殺虫性ジベンゾ（ヘテロ）アゼピン誘導体
JP2006515628A (ja) 2003-01-23 2006-06-01 アカディア ファーマシューティカルズ，インコーポレーテッド ヒト神経精神疾患を処置するためのｎ−デスメチルクロザピンの使用
CN1777594A (zh) 2003-02-22 2006-05-24 特瓦制药工业有限公司 喹迪平及其可药用盐的合成
DE10310196A1 (de) 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose
DE602004012083T2 (de) 2003-04-15 2009-04-23 Astrazeneca Ab Neue Verbindungen, die als Verstärker von Glutamatrezeptoren dienen
US20060217366A1 (en) * 2003-07-02 2006-09-28 Astrazeneca Ab Method of treating schizophrenia and other disorders
PL195728B1 (pl) 2003-07-18 2007-10-31 Helm Ag Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
RU2394030C2 (ru) * 2003-12-22 2010-07-10 Акадиа Фармасьютикалз Инк. АМИНОЗАМЕЩЕННЫЕ АНАЛОГИ ДИАРИЛ [a,d] ЦИКЛОГЕПТЕНА В КАЧЕСТВЕ МУСКАРИНОВЫХ АГОНИСТОВ И СПОСОБЫ ЛЕЧЕНИЯ ПСИХОНЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ
PT1696931E (pt) * 2003-12-22 2009-06-12 Acadia Pharm Inc Análogos diaril[a,d]ciclo-hepteno substituídos com amino utilizados como agonistas muscarínicos e métodos de tratamento de perturbações neuropsiquiátricas
US20060063754A1 (en) * 2004-09-21 2006-03-23 Edgar Dale M Methods of treating a sleep disorder
JP2008525478A (ja) 2004-12-27 2008-07-17 アストラゼネカ アクチボラグ 神経系及び精神医学系障害の治療のための代謝共役型グルタミン酸受容体アゴニストとしてのピラゾロン化合物
JP2008526839A (ja) * 2005-01-07 2008-07-24 アストラゼネカ・アクチエボラーグ １１−ピペラジン−１−イルジベンゾ［ｂ，ｆ］［１，４］チアゼピン又はその薬学的に許容される塩の新規な使用及び経口医薬組成物への新規な使用
AU2006231497A1 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of N-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
EP2099459A4 (en) 2006-12-20 2011-04-27 Astrazeneca Ab COMPOUNDS AND USES THEREOF
EP2114940A1 (en) 2007-02-09 2009-11-11 AstraZeneca AB Aza-isoindolones and their use as metabotropic glutamate receptor potentiators - 613
US7491871B2 (en) 2007-04-25 2009-02-17 Stine Seed Farm, Inc. Soybean cultivar S060299
TWI417100B (zh) 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
TW200911255A (en) 2007-06-07 2009-03-16 Astrazeneca Ab Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
CN102131791B (zh) * 2008-06-20 2014-12-24 阿斯利康(瑞典)有限公司 二苯并硫杂氮杂*衍生物及其用途

Also Published As

Publication number Publication date
AR072200A1 (es) 2010-08-11
TW201002702A (en) 2010-01-16
ZA201100488B (en) 2011-10-26
ECSP10010698A (es) 2011-01-31
JP2014098006A (ja) 2014-05-29
AU2009260905B2 (en) 2012-08-23
IL210081A0 (en) 2011-02-28
CN102131791B (zh) 2014-12-24
DK2307389T3 (da) 2013-04-02
SI2307389T1 (sl) 2013-04-30
US20110160184A1 (en) 2011-06-30
CL2010001471A1 (es) 2011-05-06
JP2011524898A (ja) 2011-09-08
JP5468068B2 (ja) 2014-04-09
PE20110029A1 (es) 2011-02-11
PT2307389E (pt) 2013-03-28
EP2307389A1 (en) 2011-04-13
EA201001889A1 (ru) 2011-08-30
MX2010014203A (es) 2011-02-22
DOP2010000393A (es) 2011-01-31
HN2010002683A (es) 2013-01-15
CU23884B1 (es) 2013-04-19
ME01516B (me) 2014-04-20
US8653257B2 (en) 2014-02-18
RS52703B (sr) 2013-08-30
HK1156308A1 (en) 2012-06-08
CN102131791A (zh) 2011-07-20
CR11860A (es) 2011-02-25
CA2728675A1 (en) 2009-12-23
EP2307389A4 (en) 2012-04-11
IL229560A (en) 2015-07-30
CY1113845T1 (el) 2016-07-27
IL210081A (en) 2013-12-31
US8158618B2 (en) 2012-04-17
BRPI0914231A2 (pt) 2015-11-03
ES2402084T3 (es) 2013-04-26
EP2307389B1 (en) 2013-01-23
KR20110019781A (ko) 2011-02-28
UY31919A (es) 2010-01-29
HRP20130234T1 (hr) 2013-04-30
CU20100252A7 (es) 2011-11-15
NI201000224A (es) 2012-03-19
WO2009154563A1 (en) 2009-12-23
US20090318415A1 (en) 2009-12-24
IL229560A0 (en) 2014-01-30
TWI488854B (zh) 2015-06-21
PL2307389T3 (pl) 2013-05-31
AU2009260905A1 (en) 2009-12-23
SV2010003769A (es) 2011-05-20
NZ590616A (en) 2012-09-28
UA105903C2 (uk) 2014-07-10
US20120202991A1 (en) 2012-08-09

Similar Documents

Publication Publication Date Title
MY157518A (en) Dibenzothiazepine derivatives and use thereof
MX2013005826A (es) Benzoxazepinas como inhibidores de fosfatidilinositol 3-cinasa/objetivo de rapamicina en mamiferos (p13k/mtor) y metodos de uso y fabricacion.
TW200833324A (en) Sulfonamide derivatives
GEP20156216B (en) Heterocyclic compound and usage thereof
CO6440551A2 (es) Compuestos pirazolo[1,5-a]pirimidina sustituida como inhibidores de trk cinasa
TW200738655A (en) Novel bicyclic sulfonamide derivatives
EA200900924A1 (ru) Циклизованные производные как ингибиторы eg-5
GEP20146102B (en) Compounds and compositions as protein kinase inhibitors
MX2008013582A (es) Derivados de pirimidina como inhibidores de fosfatidilinositol-3-c inasa.
NZ629025A (en) Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
MY152283A (en) Polo-like kinase inhibitirs
PH12013500942A1 (en) Triazolopyridine compounds
MX2009012595A (es) Derivados de espiroindolinona.
SV2011004004A (es) Composiciones del acido propano-1-sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil}-amida y el uso de las mismas
MX2010002341A (es) Derivados de bencimidazol usados como agonistas del receptor x de farnesoide.
NZ595263A (en) Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
MX2009013885A (es) Derivados de quinolina fusionados utiles como moduladores de acido gamma-aminobutirico.
WO2012071509A3 (en) Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
MX2010001742A (es) Nuevos derivados de piperazina-amida.
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
UA97256C2 (ru) Замещенные пиразолы и триазолы как ингибиторы кбв (кинезин-белок веретена)
MX2011008360A (es) Derivados de piridazinona sustituida con heteroarilo.
IN2012DN01232A (https=)
WO2009062874A3 (en) Benzimidazole derivatives and their use as fxr agonists
NZ608499A (en) 1,4-oxazepane derivatives